Insiders · Profile

Shlevin Harold H.

Director at GALECTIN THERAPEUTICS. Filing since 18 Nov 2013. CIK 0001557082

Company
Date
Role
Action
Shares
Amount
Of holding
29 Jun 2026
Director
Sold on a plan
22,268
$112.23K
77.4%
26 Jun 2026
Director
Sold on a plan
7,732
$38.66K
54.3%
17 Dec 2025
Director
Sold on a plan
24,499
$172.42K
79.0%
15 Dec 2025
Director
Sold on a plan
8,417
$53.03K
42.9%
12 Dec 2025
Director
Sold on a plan
19,793
$124.18K
63.9%
9 Dec 2025
Director
Sold on a plan
16,790
$105.21K
60.0%
8 Dec 2025
Director
Sold on a plan
159,000
$950.11K
93.4%
30 Dec 2024
Director
Bought
6,500
$7.54K
74.7%
13 Jun 2018
Chief Operating Officer
Sold, plan not stated
30,918
$240.92K
100%
12 Jun 2018
Chief Operating Officer
Sold, plan not stated
12,780
$83.07K
70.4%
11 Jun 2018
Chief Operating Officer
Sold, plan not stated
10,760
$69.94K
37.2%
8 Jun 2018
Chief Operating Officer
Sold, plan not stated
104,294
$602.05K
78.3%
7 Jun 2018
Chief Operating Officer
Sold, plan not stated
100,891
$525.27K
65.2%
6 Jun 2018
Chief Operating Officer
Sold, plan not stated
9,078
$46.75K
14.4%
5 Jun 2018
Chief Operating Officer
Sold, plan not stated
9,924
$51.18K
15.5%
4 Jun 2018
Chief Operating Officer
Sold, plan not stated
10,907
$56.17K
16.8%
1 Jun 2018
Chief Operating Officer
Sold, plan not stated
69,200
$352.92K
56.2%
31 May 2018
Chief Operating Officer
Sold, plan not stated
50,000
$250.00K
48.1%
18 Nov 2013
Chief Operating Officer
Bought
500
$3.31K
0.9%
19 decisions on file.